Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

CRBPCRBP
25 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in CORBUS PHARMACEUTICALS HLDGS

CITADEL ADVISORS LLC holds 92,154 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), worth $864,405 as of 2026-Q2. The position was decreased (-87.3% shares). CRBP represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$864,405

Current Shares

92,154

Total Value Change

+$181,405

Total Shares Change

-24,729

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
92,154
-87.3%
$864,4050.0%$9.38
0
2026-Q1
Decreased
727,060
-13.8%
$6.8M0.0%$8.21
0
2025-Q4
New
843,193
-
$6.9M0.0%$8.01
38
2025-Q2
Exited
0
-100.0%
$00.0%$7.40
0
2025-Q1
New
92,991
-
$493,7820.0%$5.52
33
2024-Q3
Exited
0
-100.0%
$00.0%$20.92
0
2024-Q2
Decreased
332,761
-9.9%
$15.1M0.0%$45.25
0
2024-Q1
New
369,167
-
$14.5M0.0%$39.24
39
2023-Q1
Exited
0
-100.0%
$00.0%$8.83
0
2022-Q4
New
6,897
-
$7620.0%$3.33
17
2022-Q3
Exited
0
-100.0%
$00.0%$5.25
0
2022-Q2
Decreased
68,957
-3.4%
$17,0000.0%$7.59
0
2022-Q1
Decreased
71,373
-93.2%
$38,0000.0%$15.36
0
2021-Q4
Increased
1M
+414.2%
$644,0000.0%$18.12
39
2021-Q3
Increased
203,497
+39.5%
$208,0000.0%$30.30
21
2021-Q2
Decreased
145,924
-20.3%
$267,0000.0%$55.20
0
2021-Q1
Increased
183,000
+67.7%
$361,0000.0%$55.50
35
2020-Q4
New
109,097
-
$136,0000.0%$38.40
34
2020-Q3
Exited
0
-100.0%
$00.0%$59.10
0
2020-Q2
Decreased
1.3M
-8.6%
$10.6M0.0%$237.30
0
2020-Q1
Increased
1.4M
+6831.0%
$7.2M0.0%$165.30
44
2019-Q4
New
19,939
-
$109,0000.0%$161.40
33
2019-Q2
Exited
0
-100.0%
$00.0%$207.90
0
2019-Q1
Increased
131,901
+12.8%
$917,0000.0%$208.50
28
2018-Q4
New
116,883
-
$683,0000.0%$176.40
34

Other major holders of CRBP: BlackRock Finance, Inc., Point72 Asset Management, L.P., STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., D. E. Shaw & Co., Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used